glp-1 obesity drugs updates today The revolution: What UAB researchers are discovering about how these work A Guide to Weight-Loss Medications:
Description
Biopotency in this context means the pharmacodynamic effect of a given amount via the intestinal route vs the same dose i.v

In vitro and in vivo preclinical studies have demonstrated that co-infusion of GLP-1 and GIP leads to improvement of glucose control and bodyweight regulation [17], compared with separate administration of each hormone

Meneilly GS, Roy-Duval C, Alawi H, et al
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Because these patches are sold as dietary supplements, they do not go through FDA review or approval before being sold
Lab Invest 94: 63-78, 2014

The glucagon component, in particular, adds effects that semaglutide and tirzepatide users do not experience, including increased thermogenesis and changes in hepatic glucose output
